Enhanced antitumor immune responses via a new agent [(131)I]-labeled dual-target immunosuppressant

ABSTRACT: Radionuclides theranostic are ideal “partners” for bispecific antibodies to explore the immune response of patients and synergistic treatment. A bispecific single-domain antibody-Fc fusion protein, KN046, exhibits a good treatment effect by binding to programmed cell death-ligand 1 (PD-L1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Chunjuan, Tian, Qiwei, Xu, Xiaoping, Li, Panli, He, Simin, Chen, Jian, Yao, Bolin, Zhang, Jianping, Yang, Ziyi, Song, Shaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816240/
https://www.ncbi.nlm.nih.gov/pubmed/36242616
http://dx.doi.org/10.1007/s00259-022-05986-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816240/
https://www.ncbi.nlm.nih.gov/pubmed/36242616
http://dx.doi.org/10.1007/s00259-022-05986-4

Ejemplares similares